Davern Capital Partners, LP: 13F holdings
CIK 20031472026Q2
| Positions | 15 |
|---|
| Reported value | $586.5m |
|---|
| Filed | 2026-08-13 |
|---|
Change since last quarter
| Positions | 15 (-2 vs prior quarter) |
|---|
| Reported value | $586.5m (+60.9%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| BNTX BIONTECH SE | 754,550 | $70.2m | 12.0% |
| ROIVANT SCIENCES LTD | 1,932,904 | $68.4m | 11.7% |
| ROYALTY PHARMA PLC | 1,155,809 | $64.8m | 11.0% |
| IONS IONIS PHARMACEUTICALS INC | 798,709 | $63.3m | 10.8% |
| INSM INSMED INC | 559,824 | $59.7m | 10.2% |
| REGN REGENERON PHARMACEUTICALS | 92,640 | $57.8m | 9.8% |
| LEGN LEGEND BIOTECH CORP | 1,191,522 | $34.4m | 5.9% |
| ALNY ALNYLAM PHARMACEUTICALS INC | 113,085 | $34.0m | 5.8% |
| NTRA NATERA INC | 118,975 | $32.3m | 5.5% |
| GPCR STRUCTURE THERAPEUTICS INC | 446,059 | $23.9m | 4.1% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2003147")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples